Every year, at least one new pathogen crosses the species barrier into humans from animals and evolves into a deadly disease, according to a recent research reported. These highly lethal viruses, such as AIDS, mad cow disease, SARS, H5N1 and now the novel coronavirus, is ravaging the world. The desire to block any possible spread of the virus from animals to humans has become unprecedentedly urgent. For this reason, we focus on the development of plant-based products to replace animal-derived products, offering safer alternatives for pharmaceutical, food and cosmetics industry, so as to protect human health.
Jiangxi Chundi Biotech Co., Ltd. is a National High-tech Enterprise integrating science, industry and trade, with a registered capital of 30 million yuan and an area of 42000 m². It is located in Jinggangshan Economic and Technological Development Zone, Ji'an City, Jiangxi Province. The company mainly produces plant-based Vitamin D and active Vitamin D analogues, plant-based Cholesterol and its derivatives. The products are widely used in Pharmaceutical, feed and food industries.
The company has complete production facilities and equipment. It has built a production line with an annual capability of 10 tons of Vitamin D3 crystals, 10 tons of 25-hydroxy Vitamin D3 crystals and 2 tons of Vitamin D2 crystals. Industrialization projects such as 20 tons of Cholesterol, and Vitamin D derivatives like Calcitriol, Alpha calcitriol and Calcipotriol etc. are established. The company has advanced fermentation, photochemical and synthetic facilities and equipment, scientific process design, reasonable equipment layout and complete safety and environmental protection measures.
Jiangxi Chundi Biotech takes part in CPHI, ICSE & bioLIVE China held in Shanghai, during Dec.16~Dec.18, 20202020-12-16
Jiangxi Chundi Biotech attend in Nanjing API meeting during Oct. 14~16, 2020.2020-10-14
Jiangxi Chundi Biotech attends in CPHI WorldWide Conference in Frankfurt, Gemany during Nov. 05~Nov.07, 20192019-11-05